ATMPs monitored by the NIHR Innovation Observatory
Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer ground-breaking new opportunities for the treatment of disease and injury. This dashboard provides an overview of ATMP medicines that have been monitored by the NIHR IO on our internal database, MInD, since April 2017. It provides the user with the details of the biosimilar products including the therapy areas, development stage, EMA designations and information on the type of innovations (eg monotherapy vs combination, cancer and rare indications).